Literature DB >> 8599407

Are chronic psychiatric patients at increased risk for developing breast cancer?

U Halbreich1, J Shen, V Panaro.   

Abstract

OBJECTIVE: The authors' goal was to assess the incidence of breast cancer among chronic psychiatric patients.
METHOD: They reviewed mammograms and charts of 275 female patients over the age of 40 in a state psychiatric hospital and 928 women of comparable age at a general hospital radiology clinic.
RESULTS: The incidence of breast cancer documented by pathology reports among the psychiatric patients was more than 3.5 times higher than that of patients at the general hospital and 9.5 times higher than the reported incidence in the general population.
CONCLUSIONS: If confirmed, the suspected higher incidence of breast cancer among the psychiatric patients might be due to medications and further underscores the need for screening mammograms for breast cancer in these patients.

Entities:  

Mesh:

Year:  1996        PMID: 8599407     DOI: 10.1176/ajp.153.4.559

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  10 in total

1.  Uptake of screening for breast cancer in patients with mental health problems.

Authors:  Ursula Werneke; Oded Horn; Alan Maryon-Davis; Simon Wessely; Stuart Donnan; Klim McPherson
Journal:  J Epidemiol Community Health       Date:  2006-07       Impact factor: 3.710

2.  Early stage breast cancer treatments for younger Medicare beneficiaries with different disabilities.

Authors:  Lisa I Iezzoni; Long H Ngo; Donglin Li; Richard G Roetzheim; Reed E Drews; Ellen P McCarthy
Journal:  Health Serv Res       Date:  2008-05-12       Impact factor: 3.402

3.  Bibliotherapy as a treatment for depression in primary care.

Authors:  Elizabeth V Naylor; David O Antonuccio; Mark Litt; Gary E Johnson; Daniel R Spogen; Richard Williams; Catherine McCarthy; Marcia M Lu; David C Fiore; Dianne L Higgins
Journal:  J Clin Psychol Med Settings       Date:  2010-09

4.  Five-year mortality of Finnish schizophrenia patients in the era of deinstitutionalization.

Authors:  Helena Rantanen; Anna-Maija Koivisto; Raimo K R Salokangas; Mika Helminen; Hannu Oja; Sami Pirkola; Kristian Wahlbeck; Matti Joukamaa
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-07-28       Impact factor: 4.328

Review 5.  Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Authors:  Peter M Haddad; Angelika Wieck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Cancer risk among users of neuroleptic medication: a population-based cohort study.

Authors:  S O Dalton; C Johansen; A H Poulsen; M Nørgaard; H T Sørensen; J K McLaughlin; P B Mortensen; S Friis
Journal:  Br J Cancer       Date:  2006-08-22       Impact factor: 7.640

7.  Identification association of drug-disease by using functional gene module for breast cancer.

Authors:  Lida Zhu; Fuxi Zhu
Journal:  BMC Med Genomics       Date:  2015-05-29       Impact factor: 3.063

8.  Mammography stages of change in middle-aged women with schizophrenia: an exploratory analysis.

Authors:  Laurie A Lindamer; Emily Wear; Georgia Robins Sadler
Journal:  BMC Psychiatry       Date:  2006-10-30       Impact factor: 3.630

9.  Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.

Authors:  A N Johnston; W Bu; S Hein; S Garcia; L Camacho; L Xue; L Qin; C Nagi; S G Hilsenbeck; J Kapali; K Podsypanina; J Nangia; Y Li
Journal:  Breast Cancer Res       Date:  2018-05-19       Impact factor: 6.466

10.  A shared genetic contribution to breast cancer and schizophrenia.

Authors:  Donghao Lu; Jie Song; Yi Lu; Katja Fall; Xu Chen; Fang Fang; Mikael Landén; Christina M Hultman; Kamila Czene; Patrick Sullivan; Rulla M Tamimi; Unnur A Valdimarsdóttir
Journal:  Nat Commun       Date:  2020-09-15       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.